There is increasing evidence that long-term peritoneal dialysis (PD) is ass
ociated with structural changes in the peritoneal membrane. These consist o
f thickening of the sub-mesothelial space owing to collagen deposition and
alterations in small blood vessel morphology. These alterations become more
pronounced with duration of PD therapy. These changes are associated with
a tendency to increasing small solute transport rate with reduced ultrafilt
ration. The relationship between these structural and functional changes re
mains unknown, but the evidence suggests that both peritonitis and exposure
to dialysate contribute. The most likely components of the fluid responsib
le for this effect are glucose and/or its degradation products generated du
ring heat sterilisation. Serial monitoring of peritoneal function is well e
stablished, but repeat biopsies are not practical. Effluent markers are not
yet of proven value but do alter in response to a change in dialysate comp
osition. Hopefully, a combination of reduced inflammation and more biocompa
tible fluids will reduce long-term changes in peritoneal membrane structure
and function with a consequent improvement in patient and technique surviv
al. (C) 2000 by the National Kidney Foundation, Inc.